SAB BIOTHERAPEUTICS INC (SABS) Stock Cash Flow
NASDAQ:SABS - Nasdaq - US78397T2024 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.28M | -34.11M | -42.19M | -18.74M | -17.14M | |||
| Depreciation Amortization | 3.61M | 4.79M | 3.65M | 3.17M | 1.49M | |||
| Change In Working Capital | 1.54M | -2.30M | 2.33M | -238.00K | 11.68M | |||
| Interest Paid | 377.80K | 374.00K | 245.00K | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | -2.21M | -2.68M | 11.10M | -7.65M | 5.96M | |||
| OPERATING CASH FLOW | -31.34M | -34.29M | -25.12M | -23.46M | 1.99M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -337.30K | -197.00K | -2.17M | -10.94M | |||
| Other Investing Activity | 24.28M | -11.63M | 44.00K | 76.00K | 0.00 | |||
| INVESTING CASH FLOW | 24.07M | -11.96M | -153.00K | -2.09M | -10.94M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -831.50K | -907.00K | -390.00K | -1.19M | 1.54M | |||
| Stock Issued/Repurchased | N/A | 20.40K | 67.16M | 2.24M | 34.35M | |||
| Other Financing Activity | -120.70K | -286.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -952.20K | -1.17M | 66.77M | 1.05M | 35.89M | |||
| Exchange Rate Effect | -170.40K | -241.20K | 18.00K | N/A | N/A | |||
| CHANGE IN CASH | -8.39M | -47.67M | 41.52M | -24.50M | 26.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -31.34M | -34.29M | -25.12M | -23.46M | 1.99M | |||
| Capital Expenditure | N/A | -337.30K | -197.00K | -2.17M | -10.94M | |||
| FREE CASH FLOW | -31.55M | -34.63M | -25.32M | -25.63M | -8.96M | |||
All data in USD